Total medical devices industry deals for June 2019 worth $7.19bn were announced globally, according to GlobalData’s deals database.
Go deeper with GlobalData
- Embed this chart
Embed this chart into your website
Copy and paste the code below into your website to display the chart.
The value marked a decrease of 21% over the previous month and a rise of 58.5% when compared with the last 12-month average of $4.54bn.
In terms of number of deals, the sector saw a rise of 14.3% over the last 12-month average with 128 deals against the average of 112 deals.
In value terms, North America led the activity with deals worth $6.49bn.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataMedical devices industry deals in June 2019: Top deals
The top five medical devices deals accounted for 90.7% of the overall value during June 2019.
The combined value of the top five medical devices deals stood at $6.52bn, against the overall value of $7.19bn recorded for the month. The top announced medical devices deal tracked by GlobalData in June 2019 was Dassault Systemes‘ $5.8bn acquisition of Medidata Solutions.
In second place was the $475m acquisition of Blue Earth Diagnostics by Bracco Imaging and in third place was 8VC, Advent Venture Partners, Deerfield ManagementLP, GE Ventures, Opaleye Management, Orbimed Advisors, Pura Vida Investments and Xeraya Capital Sdn’s $100m venture financing of Acutus Medical.
The $73m venture financing of Omada Health by Andreessen Horowitz, Cigna Ventures, Civilization Ventures, Kaiser Permanente Ventures, Norwest Venture Partners XII, Providence Ventures, Sanofi Ventures, USVP Management and Wellington Management and BPI France, Dassault Systemes, IDInvest Partners and LBO France’s venture financing of BioSerenity for $72.94m held fourth and fifth positions, respectively.
Verdict deals analysis methodology
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.
